Regulatory T Cells and Profile of FOXP3 Isoforms Expression in Peripheral Blood of Patients with Myelodysplastic Syndromes

Table 2

The characteristics of patients with MDS.

Parameter	Patients with MDS, n=76	Frequency, %
Age, years	69 (63–76)	-
Sex
Male	35	46.1 34.8; 57.3
Female	41	53.9 42.7; 65.2
MDS variant (WHO2008)
RA^1	14	18.4 9.7; 27.1
MDS associated with isolated	6	7.9 1.8; 14.0
del(5q)	5	6.6 1.0; 12.2
RARS^2	17	22.4 13.0; 31.7
RCMD^3	15	19.7 10.8; 28.7
RAEB^4-1	19	25.0 15.3; 34.7
RAEB-2
Karyotype
Normal	48	63.2 52.3; 74.0
Abnormal	28	36.8 26.0; 47.7
IPSS
Low	19	25.0 15.3; 34.7
Intermediate-1	12	15.8 7.6; 24.0
Intermediate-2	19	25.0 15.3; 34.7
High	26	34.2 23.5; 44.9

Note: The karyotype changes are described in the text. ¹RA, refractory anemia; RARS, refractory anemia with ring sideroblasts; RCMD, refractory cytopenia with multilineage dysplasia; RAEB, refractory anemia with excess blasts.